Amgen Inc. buy marge
Start price
21.06.15
/
50%
€141.91
Target price
24.05.16
€160.00
Performance (%)
-3.29%
End price
24.05.16
€134.02
Summary
This prediction ended on 24.05.16 with a price of €134.02. With a performance of -3.29%, the BUY prediction by marge finished with a loss. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Amgen Inc. | 14.603% | 14.603% | 39.306% | 42.148% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by marge for this prediction
In the thread Amgen Inc. diskutieren
Amgen
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)